| Name | 4-oxo-1H-1,7-naphthyridine-3-carboxylic acid |
|---|---|
| Synonyms |
4-oxo-1,4-dihydro-1,7-naphthyridine-3-carboxylic acid
1,7-Naphthyridine-3-carboxylicacid,4-hydroxy 1,7-Naphthyridine-3-carboxylic acid, 4-hydroxy- 4-Hydroxy-1,7-naphthyridine-3-carboxylic acid |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 423.2±45.0 °C at 760 mmHg |
| Molecular Formula | C9H6N2O3 |
| Molecular Weight | 190.156 |
| Flash Point | 209.8±28.7 °C |
| Exact Mass | 190.037842 |
| PSA | 83.05000 |
| LogP | 1.95 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.746 |
|
~%
92972-37-7 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2009/36412 A1, 2009 ; Location in patent: Page/Page column 64-65 ; WO 2009/036412 A1 |